386899002: Atovaquone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antiprotozoal\Atovaquone (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antiprotozoal\Atovaquone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Ketone (substance)\Cyclic ketone\Quinone and/or quinone derivative (substance)\Quinone\Naphthoquinone (substance)\Atovaquone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461077014 Atovaquone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481013013 Atovaquone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4497101000005112 Atovaquon da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Atovaquone (substance)	Is a	Antiprotozoal	true	Inferred relationship	Some
Atovaquone (substance)	Is a	Allergen class	false	Inferred relationship	Some
Atovaquone (substance)	Is a	Drug allergen	false	Inferred relationship	Some
Atovaquone (substance)	Is a	Naphthoquinone (substance)	true	Inferred relationship	Some
Atovaquone (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antiprotozoal	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing atovaquone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Atovaquone adverse reaction	Causative agent	True	Atovaquone (substance)	Inferred relationship	Some	1
Allergy to atovaquone	Causative agent	False	Atovaquone (substance)	Inferred relationship	Some
Atovaquone+proguanil hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some
atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some
atovaquon 750 mg/5 ml sukkerfri suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some
Product containing atovaquone and proguanil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Allergy to atovaquone	Causative agent	True	Atovaquone (substance)	Inferred relationship	Some	1
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some	2
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Atovaquone (substance)	Inferred relationship	Some	2
atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atovaquone (substance)	Inferred relationship	Some	2
atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Atovaquone (substance)	Inferred relationship	Some	2
Atovaquone- and proguanil-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
atovaquon 250 mg + proguanilhydrochlorid 100 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Atovaquone (substance)	Inferred relationship	Some	2
atovaquon 62,5 mg + proguanilhydrochlorid 25 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Atovaquone (substance)	Inferred relationship	Some	2
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atovaquone (substance)	Inferred relationship	Some	1
Atovaquone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing only atovaquone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing only atovaquone and proguanil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Atovaquone and proguanil only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing only atovaquone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atovaquone (substance)	Inferred relationship	Some	1
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Atovaquone (substance)	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461077014	Atovaquone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481013013	Atovaquone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4497101000005112	Atovaquon	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)